Prognostic impact of a past or synchronous second cancer in diffuse large B cell lymphoma

被引：11

作者：

Tanba, Kazuna ^{[1
,2
]}

Chinen, Yoshiaki ^{[1
,2
]}

Uchiyama, Hitoji ^{[2
,3
]}

Uoshima, Nobuhiko ^{[2
,4
]}

Shimura, Kazuho ^{[2
,5
]}

Fuchida, Shinichi ^{[2
,6
]}

Kiyota, Miki ^{[2
,7
]}

Nakao, Mitsushige ^{[2
,8
]}

Shimura, Yuji ^{[1
,2
]}

Kobayashi, Tsutomu ^{[1
,2
]}

Horiike, Shigeo ^{[1
,2
]}

Wada, Katsuya ^{[2
,7
]}

Shimazaki, Chihiro ^{[2
,6
]}

Kaneko, Hiroto ^{[2
,5
]}

Kobayashi, Yutaka ^{[2
,4
]}

Taniwaki, Masafumi ^{[2
,5
]}

Kuroda, Junya ^{[1
,2
]}

机构：

[1] Kyoto Prefectural Univ Med, Dept Med, Div Hematol & Oncol, Kyoto, Japan

[2] Kyoto Clin Hematol Study Grp, Kyoto, Japan

[3] Japanese Red Cross Kyoto Daiichi Hosp, Dept Hematol, Kyoto, Japan

[4] Japanese Red Cross Kyoto Daini Hosp, Dept Hematol, Kyoto, Japan

[5] Aiseikai Yamashina Hosp, Dept Hematol, Kyoto, Japan

[6] Kyoto Kuramaguchi Med Ctr, Japan Community Hlth Care Org, Dept Hematol, Kyoto, Japan

[7] Matsushita Mem Hosp, Dept Hematol, Osaka, Japan

[8] Otsu Municipal Hosp, Dept Internal Med, Otsu, Shiga, Japan

来源：

BLOOD CANCER JOURNAL | 2018年 / 8卷

关键词：

SURVIVORS; RISK;

D O I：

10.1038/s41408-017-0043-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：5

共 50 条

[21] Prognostic Impact of Gastrointestinal Involvement in Newly Diagnosed Diffuse Large B-Cell Lymphoma
Kasouha, David
Lehners, Nicola
Kriegsmann, Katharina
Egerer, Gerlinde
Ho, Anthony D.
Witzens-Harig, Mathias
BLOOD, 2018, 132
[22] Prognostic impact of C-REL expression in diffuse large B-cell lymphoma
Curry C.V.
Ewton A.A.
Olsen R.J.
Logan B.R.
Preti H.A.
Liu Y.-C.
Perkins S.L.
Chang C.-C.
Journal of Hematopathology, 2009, 2 (1) : 20 - 26
[23] The Prognostic Impact of Comorbidity, Nutritional and Performance Status on Patients with Diffuse Large B Cell Lymphoma
Saglam, B.
Albayrak, M.
Yildiz, A.
Tiglioglu, P.
Tiglioglu, M.
Aras, M. R.
Yilmaz, F.
Maral, S.
Ozturk, H. B. A.
NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2023, 26 (10) : 1512 - 1518
[24] Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era
Seki, Ritsuko
Ohshima, Koichi
Fujisaki, Tomoaki
Uike, Naokuni
Kawano, Fumio
Gondo, Hisashi
Makino, Shigeyoshi
Eto, Tetsuya
Moriuchi, Yukiyoshi
Taguchi, Fumihiro
Kamimura, Tomohiko
Tsuda, Hiroyuki
Ogawa, Ryosuke
Shimoda, Kazuya
Yamashita, Kiyoshi
Suzuki, Keiko
Suzushima, Hitoshi
Tsukazaki, Kunihiro
Higuchi, Masakazu
Utsunomiya, Atae
Iwahashi, Masahiro
Imamura, Yutaka
Tamura, Kazuo
Suzumiya, Junji
Yoshida, Minoru
Abe, Yasunobu
Matsumoto, Tadashi
Okamura, Takashi
CANCER SCIENCE, 2009, 100 (10): : 1842 - 1847
[25] Prognostic impact of extranodal involvement in diffuse large B-cell lymphoma in the rituximab era
Takahashi, Hiroyuki
Tomita, Naoto
Yokoyama, Masahiro
Tsunoda, Saburo
Yano, Takahiro
Murayama, Kayoko
Hashimoto, Chizuko
Tamura, Kazuo
Sato, Kazuya
Ishigatsubo, Yoshiaki
CANCER, 2012, 118 (17) : 4166 - 4172
[26] Prognostic Significance of Cell of Origin Subclassification in Diffuse Large B Cell Lymphoma
Dawod, Muath
Gomez-Gelvez, Juan
Mattour, Ahmad
Inamdar, Kedar V.
Janakiraman, Nalini
BLOOD, 2012, 120 (21)
[27] Hyperfibrinogenemia is a poor prognostic factor in diffuse large B cell lymphoma
Jun-Ying Niu
Tian Tian
Hua-Yuan Zhu
Jin-Hua Liang
Wei Wu
Lei Cao
Rui-Nan Lu
Li Wang
Jian-Yong Li
Wei Xu
Annals of Hematology, 2018, 97 : 1841 - 1849
[28] Molecular prognostic factors in diffuse large B-cell lymphoma
Morgensztern D.
Lossos I.S.
Current Treatment Options in Oncology, 2005, 6 (4) : 269 - 277
[29] MicroRNA Is Prognostic Indicator in Patients with Diffuse Large B Cell Lymphoma
Lahav, Meir
Ram, Ron
Kushnir, Michal
Spilberg, Ofer
Yanai, Gila Lithwick
Beeri, Osnat
Hoshen, Moshe
Feinmesser, Maora
BLOOD, 2008, 112 (11) : 299 - 300
[30] Hyperfibrinogenemia is a poor prognostic factor in diffuse large B cell lymphoma
Niu, Jun-Ying
Tian, Tian
Zhu, Hua-Yuan
Liang, Jin-Hua
Wu, Wei
Cao, Lei
Lu, Rui-Nan
Wang, Li
Li, Jian-Yong
Xu, Wei
ANNALS OF HEMATOLOGY, 2018, 97 (10) : 1841 - 1849

← 1 2 3 4 5 →